EPH156 Modelling Herpes Zosters Burden and Public Health Impact of Adjuvanted Recombinant Zoster Vaccine Among Adults Aged ≥50 Years Old in Seven Countries in Central and South America

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.1198
https://www.valueinhealthjournal.com/article/S1098-3015(23)04328-0/fulltext
Section Title :
Section Order : 10682
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04328-0&doi=10.1016/j.jval.2023.09.1198
HEOR Topics :
Tags :
Regions :